JP2022516351A5 - - Google Patents

Info

Publication number
JP2022516351A5
JP2022516351A5 JP2021539418A JP2021539418A JP2022516351A5 JP 2022516351 A5 JP2022516351 A5 JP 2022516351A5 JP 2021539418 A JP2021539418 A JP 2021539418A JP 2021539418 A JP2021539418 A JP 2021539418A JP 2022516351 A5 JP2022516351 A5 JP 2022516351A5
Authority
JP
Japan
Prior art keywords
antibody
amino acid
acid sequence
seq
heavy chain
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2021539418A
Other languages
English (en)
Japanese (ja)
Other versions
JP2022516351A (ja
JP7512290B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/EP2020/050203 external-priority patent/WO2020144178A1/en
Publication of JP2022516351A publication Critical patent/JP2022516351A/ja
Publication of JP2022516351A5 publication Critical patent/JP2022516351A5/ja
Application granted granted Critical
Publication of JP7512290B2 publication Critical patent/JP7512290B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2021539418A 2019-01-07 2020-01-07 抗tigit抗体 Active JP7512290B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201962789466P 2019-01-07 2019-01-07
US62/789,466 2019-01-07
PCT/EP2020/050203 WO2020144178A1 (en) 2019-01-07 2020-01-07 Anti-tigit antibodies

Publications (3)

Publication Number Publication Date
JP2022516351A JP2022516351A (ja) 2022-02-25
JP2022516351A5 true JP2022516351A5 (cg-RX-API-DMAC7.html) 2023-01-19
JP7512290B2 JP7512290B2 (ja) 2024-07-08

Family

ID=69177132

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2021539418A Active JP7512290B2 (ja) 2019-01-07 2020-01-07 抗tigit抗体

Country Status (12)

Country Link
US (1) US12312401B2 (cg-RX-API-DMAC7.html)
EP (1) EP3908609A1 (cg-RX-API-DMAC7.html)
JP (1) JP7512290B2 (cg-RX-API-DMAC7.html)
KR (1) KR20210113282A (cg-RX-API-DMAC7.html)
CN (1) CN113993894B (cg-RX-API-DMAC7.html)
AU (1) AU2020206588A1 (cg-RX-API-DMAC7.html)
BR (1) BR112021013397A2 (cg-RX-API-DMAC7.html)
CA (1) CA3125800A1 (cg-RX-API-DMAC7.html)
IL (1) IL284584A (cg-RX-API-DMAC7.html)
MX (1) MX2021008216A (cg-RX-API-DMAC7.html)
SG (1) SG11202107474RA (cg-RX-API-DMAC7.html)
WO (1) WO2020144178A1 (cg-RX-API-DMAC7.html)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL272227B2 (en) * 2017-07-27 2025-09-01 iTeos Belgium SA Anti-tigit antibodies
US11376255B2 (en) 2018-09-11 2022-07-05 iTeos Belgium SA Thiocarbamate derivatives as A2A inhibitors, pharmaceutical composition thereof and combinations with anticancer agents
TW202210514A (zh) 2020-06-02 2022-03-16 美商阿克思生物科學有限公司 針對tigit的抗體
CA3189730A1 (en) * 2020-08-05 2022-02-10 Crystal Bioscience Inc. Anti-tigit antibody and methods of use thereof
US20240002500A1 (en) * 2020-11-23 2024-01-04 Guangdong Fapon Biopharma Inc. Anti-TIGIT Antibody or Antigen-Binding Fragment Thereof
CN119156228A (zh) 2022-05-02 2024-12-17 艾库斯生物科学有限公司 抗tigit抗体及其用途
WO2024039920A1 (en) * 2022-08-15 2024-02-22 Mbrace Therapeutics, Inc. Cell-free methods of producing antibodies to intracellular targets

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5892019A (en) 1987-07-15 1999-04-06 The United States Of America, As Represented By The Department Of Health And Human Services Production of a single-gene-encoded immunoglobulin
US8877688B2 (en) 2007-09-14 2014-11-04 Adimab, Llc Rationally designed, synthetic antibody libraries and uses therefor
WO2009036379A2 (en) 2007-09-14 2009-03-19 Adimab, Inc. Rationally designed, synthetic antibody libraries and uses therefor
MX381912B (es) 2010-07-16 2025-03-13 Adimab Llc Colecciones de anticuerpos.
HK1221908A1 (zh) 2013-04-29 2017-06-16 Adimab, Llc 多特异(polyspecificity)试剂,其制备方法和用途
CA2957722C (en) 2014-08-19 2022-05-31 Merck Sharp & Dohme Corp. Anti-tigit antibodies
AR103268A1 (es) 2014-12-23 2017-04-26 Bristol Myers Squibb Co Anticuerpos contra tigit
TWI715587B (zh) 2015-05-28 2021-01-11 美商安可美德藥物股份有限公司 Tigit結合劑和彼之用途
CN115925931A (zh) 2015-08-14 2023-04-07 默沙东公司 抗tigit抗体
SG10202007764TA (en) 2015-09-25 2020-09-29 Genentech Inc Anti-tigit antibodies and methods of use
MX2018010485A (es) 2016-03-04 2019-01-10 Jn Biosciences Llc Anticuerpos para inmunoreceptor de celulas t con dominios de ig e itim (tigit).
KR101837936B1 (ko) 2016-08-31 2018-03-13 송철기 금속 이온을 이용한 살균수 생성장치
IL272227B2 (en) * 2017-07-27 2025-09-01 iTeos Belgium SA Anti-tigit antibodies
WO2019023504A1 (en) 2017-07-27 2019-01-31 Iteos Therapeutics Sa ANTI-TIGIT ANTIBODIES
KR101859195B1 (ko) 2017-10-13 2018-05-17 강선영 석션 기능을 갖는 ret방식 고주파 마사지기

Similar Documents

Publication Publication Date Title
JP2025111463A5 (cg-RX-API-DMAC7.html)
JP2017535257A5 (cg-RX-API-DMAC7.html)
IL276695A (en) Antibodies, pharmaceutical compositions and uses thereof
JP2017048240A5 (cg-RX-API-DMAC7.html)
JP2020514310A5 (cg-RX-API-DMAC7.html)
RU2019111722A (ru) Антитела против siglec-15 и способы их применения
JP2015514110A5 (cg-RX-API-DMAC7.html)
RU2014122990A (ru) Способы комбинированной терапии с применением молекул, связывающихся с psl и pcrv pseudomonas
HRP20221083T1 (hr) Kombinirana terapija bispecifičnom antigen vezujućom molekulom koja aktivira t stanice i antagonistom vezivanja osi pd-1
FI3740504T3 (fi) CD70-yhdistelmähoito
JP2020502271A5 (cg-RX-API-DMAC7.html)
JP2017514795A5 (cg-RX-API-DMAC7.html)
JP2013542194A5 (cg-RX-API-DMAC7.html)
JP2015535828A5 (cg-RX-API-DMAC7.html)
JP2015504421A5 (cg-RX-API-DMAC7.html)
JP2022533538A5 (cg-RX-API-DMAC7.html)
JP2025131696A5 (cg-RX-API-DMAC7.html)
RU2018123717A (ru) Комбинированные лечения, их применения и способы
JP2022509156A5 (cg-RX-API-DMAC7.html)
RU2014143785A (ru) Фармацевтическая композиция для лечения и/или предотвращения рака печени
JP2021510736A5 (cg-RX-API-DMAC7.html)
JP2012532851A5 (cg-RX-API-DMAC7.html)
JP2017512759A5 (cg-RX-API-DMAC7.html)
JP2015503909A5 (cg-RX-API-DMAC7.html)
JP2020522280A5 (cg-RX-API-DMAC7.html)